Drs. Palanca and Lenze have received a grant from the National Institute of Mental Health (NIMH) to begin the Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) clinical trial.
Dr. Michael Lanspa sits down with Pratik Sinha to discuss their article “Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids”.
While the Record coverage focuses on Drs. Peter Nagele and Charles Conway who conceptualized the study, successfully secured funding, and led the dissemination of our findings, Dr. Palanca took over the project and human studies administration when Dr. Nagele departed from WU, and Palanca also served as a key member of the investigative team. The findings cap off years of and clinical investigations at the School of Medicine, exploring the use of nitrous oxide as a novel treatment for depression.
In addition to pursuing his research, Dr. Sinha will be working clinically and educating residents and fellows in the Barnes-Jewish Hospital ICUs.
Dr. Haroutounian also serves as Associate Professor of Anesthesiology and an Adjunct Assistant Professor of Pharmacy Practice at the St. Louis College of Pharmacy.
Simon Haroutounian, PhD has graciously agreed to serve as the interim Chief of the Division of Clinical and Translational Research (DoCTR). In this role, Dr. Haroutounian will be responsible for mentoring trainees and junior and mid-level faculty in clinical and translational research, promoting collaborative efforts both within the Department and across the WU School of […]
It is our pleasure to announce that Dr. Tanya Wildes has accepted a secondary appointment in the Department of Anesthesiology in our Division of Clinical and Translational Research (DoCTR). Dr. Wildes is internationally recognized as a thought leader and research expert in oncology and in geriatric medicine. As such, we anticipate that she will add […]